CLINICAL RESULTS ON BRL 28500 (CLAVULANIC ACID-TICARCILLIN) FOR VARIOUS INFECTIONS IN THE FIELD OF SURGERY
BRL 28500 is an injectable antibiotic formulation of ticarcillin (TIPC) as the disodium salt and clavulanic acid (CVA) as the potassium salt in the ratio of 15 parts to 1 part. The formulation with the β-lactamase inhibitor CVA is intended to broaden the antibacterial spectrum of TIPC to additionall...
Saved in:
Published in: | CHEMOTHERAPY Vol. 34; no. Supplement4; pp. 818 - 832 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English Japanese |
Published: |
Japanese Society of Chemotherapy
1986
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!